PMID- 38007756 OWN - NLM STAT- MEDLINE DCOM- 20240130 LR - 20240130 IS - 1879-8365 (Electronic) IS - 0926-9630 (Linking) VI - 308 DP - 2023 Nov 23 TI - Bio Informatics Analysis of the Relationship Between Mammalian Target of Rapamycin and Colorectal Cancer. PG - 322-328 LID - 10.3233/SHTI230856 [doi] AB - OBJECTIVE: The purpose of this paper is to promote the medical treatment of colorectal cancer in our country and to save the lives of patients with colorectal cancer by studying mammalian target of rapamycin (mTOR) and the biologic information analysis of colorectal cancer. METHODS: We analyzed mTOR expression and survival differences using data from Coad & read from the TCGA public database and explored the coexpression regulatory network of mTOR. mTOR-regulated mirnas were screened using the Linked Omics database. In addition, we explored the association of mTOR with drug sensitivity, immune cell correlations, microsatellite deletions, tumor mutational burden, and mutational analysis. RESULTS: The expression and survival of mTOR were significant different in colorectal cancer, and were related to the sensitivity of Bleomycin, Cisplatin and Gemcitabine. mTOR is associated with dendritic cell activation, NK cell dormancy, dendritic cell dormancy, and eosinophil granulocyte. mTOR is associated with microsatellite deletions, and tumor mutational load. CONCLUSIONS: Based on these findings, we consumer mTOR as a biomarker for the diagnosis and prognosis of colorectal cancer. FAU - Han, Lihong AU - Han L AD - Key Laboratory of Translational Oncology, Putian University, Putian, CN. FAU - Lin, Lirong AU - Lin L AD - Key Laboratory of Translational Oncology, Putian University, Putian, CN. FAU - Chen, Jingru AU - Chen J AD - Key Laboratory of Translational Oncology, Putian University, Putian, CN. FAU - Yan, Bin AU - Yan B AD - Key Laboratory of Translational Oncology, Putian University, Putian, CN. LA - eng PT - Journal Article PL - Netherlands TA - Stud Health Technol Inform JT - Studies in health technology and informatics JID - 9214582 RN - 0 (MicroRNAs) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) MH - Humans MH - Cell Line, Tumor MH - *Colorectal Neoplasms/diagnosis/genetics MH - *MicroRNAs/genetics MH - Prognosis MH - *TOR Serine-Threonine Kinases/metabolism OTO - NOTNLM OT - bioinformatics OT - colorectal cancer OT - mammalian target of rapamycin OT - signaling pathways EDAT- 2023/11/26 18:41 MHDA- 2023/11/28 06:42 CRDT- 2023/11/26 15:21 PHST- 2023/11/28 06:42 [medline] PHST- 2023/11/26 18:41 [pubmed] PHST- 2023/11/26 15:21 [entrez] AID - SHTI230856 [pii] AID - 10.3233/SHTI230856 [doi] PST - ppublish SO - Stud Health Technol Inform. 2023 Nov 23;308:322-328. doi: 10.3233/SHTI230856.